BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36033439)

  • 1. The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities.
    Hinneh JA; Gillis JL; Moore NL; Butler LM; Centenera MM
    Front Oncol; 2022; 12():982231. PubMed ID: 36033439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer.
    Mele V; Sokol L; Kölzer VH; Pfaff D; Muraro MG; Keller I; Stefan Z; Centeno I; Terracciano LM; Dawson H; Zlobec I; Iezzi G; Lugli A
    Oncotarget; 2017 Sep; 8(41):70617-70629. PubMed ID: 29050306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis.
    Minato A; Kudo Y; Noguchi H; Kohi S; Hasegawa Y; Sato N; Hirata K; Fujimoto N
    Cancer Genomics Proteomics; 2023; 20(2):203-210. PubMed ID: 36870687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling.
    Tolg C; Milojevic M; Qi FW; Pavanel HA; Locke MEO; Ma J; Price M; Nelson AC; McCarthy JB; Hill KA; Turley EA
    Breast Cancer Res; 2023 Jun; 25(1):74. PubMed ID: 37349798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
    Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells.
    Assmann V; Marshall JF; Fieber C; Hofmann M; Hart IR
    J Cell Sci; 1998 Jun; 111 ( Pt 12)():1685-94. PubMed ID: 9601098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.
    Shigeishi H; Higashikawa K; Takechi M
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1629-40. PubMed ID: 24676428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression?
    Telmer PG; Tolg C; McCarthy JB; Turley EA
    Commun Integr Biol; 2011 Mar; 4(2):182-5. PubMed ID: 21655434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
    Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
    PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.
    Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN
    Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma.
    Shigeeda W; Shibazaki M; Yasuhira S; Masuda T; Tanita T; Kaneko Y; Sato T; Sekido Y; Maesawa C
    Oncotarget; 2017 Nov; 8(55):93729-93740. PubMed ID: 29212185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
    Wang D; Narula N; Azzopardi S; Smith RS; Nasar A; Altorki NK; Mittal V; Somwar R; Stiles BM; Du YN
    Oncotarget; 2016 Jun; 7(26):39957-39969. PubMed ID: 27220886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
    Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
    Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hyaluronan receptor RHAMM in noradrenergic fibers contributes to axon growth capacity of locus coeruleus neurons in an intraocular transplant model.
    Nagy JI; Price ML; Staines WA; Lynn BD; Granholm AC
    Neuroscience; 1998 Sep; 86(1):241-55. PubMed ID: 9692758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.
    Wang C; Thor AD; Moore DH; Zhao Y; Kerschmann R; Stern R; Watson PH; Turley EA
    Clin Cancer Res; 1998 Mar; 4(3):567-76. PubMed ID: 9533523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased RHAMM expression relates to ovarian cancer progression.
    Buttermore ST; Hoffman MS; Kumar A; Champeaux A; Nicosia SV; Kruk PA
    J Ovarian Res; 2017 Sep; 10(1):66. PubMed ID: 28954627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
    Esguerra KV; Tolg C; Akentieva N; Price M; Cho CF; Lewis JD; McCarthy JB; Turley EA; Luyt LG
    Integr Biol (Camb); 2015 Dec; 7(12):1547-60. PubMed ID: 26456171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells.
    Chen YT; Chen Z; Du YN
    Oncotarget; 2018 Apr; 9(30):20941-20952. PubMed ID: 29765511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival.
    He X; Liao W; Li Y; Wang Y; Chen Q; Jin J; He S
    Oncol Lett; 2015 Dec; 10(6):3639-3646. PubMed ID: 26788183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation.
    Carvalho AM; Soares da Costa D; Paulo PMR; Reis RL; Pashkuleva I
    Acta Biomater; 2021 Jan; 119():114-124. PubMed ID: 33091625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.